“Sr9009” 30MG per ML 30ML

not for human use must be 18 to purchase

Buy SR9009 for Sale

SR9009, also known as Stenabolic, is a synthetic REV-ERB agonist. In research studies conducted on mice, SR9009 was found to stimulate weight loss, lower triglyceride and total cholesterol levels, and induce a significant reduction in osteoarthritic pain. SR9009 has demonstrated lethality against specific types of cancer cells in animal studies. Preclinical research further reports that it increased running endurance and exercise capacity. Additionally, it lowered anxiety levels among animal test subjects. Patriot SARMs sells SR9009 for laboratory research use only.  

What is SR 9009?

SR9009, also known as Stenabolic, is a synthetic REV-ERB agonist. REV-ERBs are proteins that play a crucial role in regulating circadian rhythms and metabolism in the body. They influence lipid and glucose metabolism, sleep, and energy expenditure. SR9009 was initially developed by Scripps Research Institute as a potential treatment for various metabolic diseases, such as obesity and diabetes. Preclinical research suggests that it has the potential to induce significant weight and fat loss. [R] Animal studies have shown that SR9009 could boost heart health. It has been observed to lower triglyceride, total cholesterol, and LDL (or ‘bad) cholesterol levels. SR9009 has also been found to reduce the size of blood vessel lesions in mice. [R][R][R] In a cell-based study, SR9009 was lethal against chemo-sensitive and chemo-resistant small-cell lung cancer (SCLC) cells. Another study highlighted its efficacy against cancer cells extracted from the breast, colon, leukemia, and other tumor types. [R][R]  

How Does SR9009 Work?

SR9009 works by binding to and activating a specific REV-ERB in the body. [R] The human body has two types of REB-ERB proteins: REV-ERBα and REV-ERBβ. Research shows that SR9009 targets REV-ERBα, a nuclear receptor that regulates metabolism and circadian rhythm. REV-ERBα also controls the body’s response to inflammation. [R] In addition, studies have revealed that SR9009 can inhibit SCN (suprachiasmatic nucleus), the body’s internal clock. SCN regulates sleep patterns and the release of various hormones, such as cortisol and melatonin. It also influences behavior and mood. [R]  

SR9009 Research

Various animal and cell-based studies have investigated the potential effects of SR 9009 Stenabolic on body weight, heart health, and lean muscle mass. Its effects on anxiety, fat mass, and skeletal muscle growth have also been studied. Here are the key findings:  

1. SR 9009 and Body Weight

Preclinical research suggests that SR 9009 could stimulate weight loss. In an animal study, three groups of mice were treated with SR9009. The first group contained mice with regular body weight, and the remaining two groups contained genetically obese mice and diet-induced obese mice, respectively. [R] Results showed that the 1^stgroup experienced significant fat loss (and, in turn, weight loss) after being given SR 9009 for 7 days. Additionally, Stenabolic SR 9009 treatment produced a decrease in the number of fat-storing cells in the body. [R] In the 2^nd group, mice treated with SR9009 lost 60% more weight than those given a placebo. Lastly, in the 3^rd group, SR 9009 treatment stopped weight gain after 12 days. [R]  

2. SR 9009 and Heart Health

SR9009 could potentially improve various markers of heart health. According to a preclinical study, mice treated with SR 9009 for 7 to 10 days experienced a significant reduction in total cholesterol and triglyceride levels. [R] Another animal study has reported that Stenabolic treatment reduced low-density lipoprotein (LDL or ‘bad’) cholesterol levels in mice on a high-cholesterol diet. [R] A third study investigated its effects on the heart health of genetically modified mice. The group under observation was susceptible to the hardening of the arteries. After seven weeks of SR9009 treatment, the size of their blood vessel lesions had greatly reduced. [R]  

3. SR 9009 and Cancer

In animal studies, SR 9009 has shown significant efficacy against different types of cancers. For instance, a cell-based study showed that this REV-ERB agonist was lethal to chemo-sensitive and chemo-resistant cells. These cells were associated with small-cell lung cancer (SCLC), which affects about 30,000 to 35,000 people in the US each year. [R] Another study reported that its cytotoxic effects may extend beyond SCLC. SR 9009 could also be lethal to the survival of cancer cells derived from breast, colon, leukemia, and other tumor types. That, too, while exerting minimal toxic effects on normal cells. [R][R]  

4. SR 9009 and Endurance

Multiple studies show that the activation of REV-ERBα improves muscle oxidative function, which leads to increased endurance. This was also demonstrated in a mice study in which a group treated with SR9009 covered more distance and ran for longer periods than members of the control group. Significantly, the Stenabolic group had a 40x higher running capacity than the untreated group. [R]  

5. SR 9009 and Wakefulness

Multiple studies point to conflicting SR9009 effects on wakefulness. A mice study revealed that when injected during the daytime, it made mice more active for the next 12 hours than members of the control group. However, SR9009 injections produced no effect when they were administered during the night. [R][R]  

6. SR 9009 and Anxiety

Stenabolic has demonstrated anti-anxiety effects in animal studies. A cell-based study reported that SR treatment (2 injections/day for 3 – 10 days) reduced anxiety-like behavior in mice. Notably, the reduction in anxiety levels was as high as that achieved by benzodiazepine, an approved anti-anxiety medication. [R]  

7. SR 9009 and Inflammation

Multiple animal studies show that SR9009 may possess anti-inflammatory properties. A recent study shows that SR9009 reduced inflammation in the body by inhibiting the production of IL-1B. IL-1B is a pro-inflammatory cytokine, meaning it promotes inflammation in the body. It’s thus been a target of therapies designed to reduce inflammation. [R] In another study, this REV-ERB agonist reduced the production of TNF-α, a protein that causes inflammation in response to infection. [R]  

Frequently Asked Questions

Is SR 9009 a SARM?

SR 9009 is a selective androgen receptor modulator that belongs to the class of chemicals known as synthetic REV-ERB agonists. In preclinical studies, it has demonstrated the ability to burn fat, cause weight loss, and reduce inflammation.  

Is SR 9009 legal?

SR9009 is 100% legal to buy and sell for research purposes. It’s not approved for human consumption.  

Where to Buy SR 9009 for Sale?

Patriot SARMs is the best place to buy SR 9009 for sale. Every selective androgen receptor modulator that we sell comes with a 3rd-party issued Certificate of Analysis. We also offer great customer service, fast shipping, and multiple payment methods to showcase why we’re the best SARMs supplier.  

Conclusion

SR9009 Stenabolic is a synthetic REV-ERB agonist that induced weight loss, improved heart health, and lowered anxiety levels in animal studies. However, in the absence of human trials, it’s unclear whether these effects would extend to humans. Patriot SARMs sells SR9009 for laboratory and research use only, not human consumption.